<DOC>
	<DOCNO>NCT00262275</DOCNO>
	<brief_summary>To investigate effect different dosage aspirin platelet aggregation determine possible mechanism aspirin resistance , intend compare effect low , medium dose aspirin clopidogrel ( alternative antiplatelet agent ) patient coronary artery bypass surgery .</brief_summary>
	<brief_title>Optimum Platelet Inhibition After Coronary Bypass Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>We intend invite patient age 18 80 proceeding primary elective coronary artery bypass surgery , able give inform consent . Preoperative exclusion criterion : patient stop aspirin 7 day prior surgery patient concomitant NSAIDS patient previous history platelet disorder , splenectomy haematological disorder patient aspirin induced asthma patient contraindication aspirin ( GI bleed ) patient medication may result serious drug interaction aspirin ( warfarin ) Women childbearing potential Patients le 18 year If inform consent obtain If reason consultant surgeon anaesthetist deem appropriate Operative exclusion criterion : â€¢ Concomitant procedures Postoperative exclusion criterion : patient receive platelet transfusion patient receive NSAIDS requirement intra aortic balloon pump support failure extubation within 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>